Impact of Body Composition on Early Recurrence and Outcomes in Resectable PDAC
Overview
This study demonstrates that CT-quantified body composition parameters, including skeletal muscle index and visceral fat index, are significantly associated with early recurrence and long-term survival in patients with resectable pancreatic ductal adenocarcinoma (PDAC). These findings suggest that body composition metrics can serve as valuable predictors for early tumor relapse and overall prognosis.
Background
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer with poor prognosis, largely due to a high rate of tumor recurrence after surgical resection. Early recurrence (ER), defined as relapse within one year post-surgery, occurs in approximately 50% of patients and is linked to worse survival outcomes. While tumor characteristics have traditionally been used to predict recurrence, recent evidence indicates that body composition, including muscle quality and fat distribution, also plays a critical role in PDAC prognosis. CT imaging, routinely used in PDAC diagnosis, offers a noninvasive method to quantify these body composition parameters.
Data Highlights
Body Composition Parameter
Measurement Method
HU Range
Index Normalization
Skeletal Muscle Area (SMA)
CT at L3 vertebra level
-29 to +150 HU
Normalized to height squared as Skeletal Muscle Index (SMI)
Visceral Fat Area (VFA)
CT at L3 vertebra level
-150 to -50 HU
Normalized to height squared as Visceral Fat Index (VFI)
Subcutaneous Fat Area (SFA)
CT at L3 vertebra level
-190 to -30 HU
Normalized to height squared as Subcutaneous Fat Index (SFI)
Intermuscular Fat Area (IMFA)
CT at L3 vertebra level
-190 to -30 HU
Normalized to height squared as Intermuscular Fat Index (IMFI)
Key Findings
Early recurrence (ER) within 1 year after surgery occurred in approximately 50% of patients with resectable PDAC.
Reduced skeletal muscle quality and increased visceral fat accumulation, as measured by CT, were strongly associated with higher rates of ER and poorer long-term survival.
Body composition parameters can be reliably quantified using routine preoperative CT scans at the L3 vertebral level.
Inflammation-based prognostic indexes and tumor markers were collected but body composition provided additional predictive value for ER.
These findings were validated in an external patient cohort, supporting the generalizability of the results.
Clinical Implications
Routine assessment of body composition using preoperative CT scans should be integrated into clinical practice for patients with resectable PDAC. Identifying patients with low skeletal muscle index or high visceral fat index can help stratify risk for early recurrence, enabling personalized surveillance and tailored therapeutic interventions to improve outcomes.
Conclusion
CT-derived body composition metrics are valuable predictors of early recurrence and overall survival in resectable PDAC. Incorporating these parameters into clinical workflows may enhance prognostic accuracy and guide individualized patient management.
References
Pancreatic Cancer Statistics and Prognosis [1-5]
Body Composition and PDAC Outcomes [6-11]
CT Imaging and Body Composition Quantification [12-14]
Inflammation-based Prognostic Index Calculation [15]
AJCC TNM Staging System 8th Edition [16]
Postoperative Surveillance and Recurrence Definitions [17]
